PINK1 Q456X

PINK1 (PTEN-induced kinase 1) is a mitochondrial quality control protein that plays a crucial protective role in neurons by identifying damaged mitochondria and targeting them for removal through a process called mitophagy [1][2]. Loss-of-function mutations in the PINK1 gene are a primary cause of autosomal recessive early-onset Parkinson's disease, where two defective copies of the gene lead to symptoms typically appearing before age 50 [1][4][6]. The protein normally functions by phosphorylating (adding chemical tags to) both ubiquitin molecules and another protein called Parkin at a specific location (serine 65), which triggers a cascade that eliminates dysfunctional mitochondria before they can damage the cell [1][2]. The Q456X variant represents a nonsense mutation, meaning the genetic code contains a premature stop signal at position 456 where the amino acid glutamine (Q) should be located. This creates a severely truncated protein that is cut short well before its natural endpoint, eliminating approximately the C-terminal third of the full-length PINK1 protein. Such truncations typically result in complete loss of protein function, as critical domains required for kinase activity, substrate binding, and mitochondrial localization are absent from the truncated product [1]. The AlphaFold2 structural prediction for this truncated variant yields a moderate average confidence score (pLDDT of 72.4), which indicates substantial uncertainty in the predicted structure. Confidence scores below 70 generally reflect regions where the algorithm cannot reliably predict the three-dimensional arrangement, suggesting that the truncated protein may lack stable tertiary structure or may adopt multiple unstable conformations. Given that this variant removes essential functional domains entirely, the moderate confidence likely reflects both the loss of stabilizing structural elements normally present in the C-terminal region and potential destabilization of remaining domains that would normally interact with the missing portions. The functional consequences of Q456X are severe and well-established through the broader literature on PINK1 loss-of-function variants. Without functional PINK1, damaged mitochondria accumulate in neurons, leading to disrupted calcium homeostasis (the cell's ability to regulate calcium levels), increased oxidative stress, and eventual neuronal death, particularly affecting dopamine-producing neurons in the substantia nigra region of the brain [1][3]. Neurons harboring Parkinson's disease-associated PINK1 variants show defects in mitochondrial calcium regulation and disrupted contact sites between mitochondria and the endoplasmic reticulum (another cellular organelle), rendering cells more susceptible to damage [3]. Additionally, the PINK1-Parkin pathway can be further disrupted by other cellular factors, such as microRNAs that inhibit autophagy machinery, potentially exacerbating the loss of mitochondrial quality control [2]. Clinically, PINK1 mutations like Q456X are found across diverse populations and represent a well-recognized cause of familial Parkinson's disease [4][5][6]. Genetic studies in various ethnic groups, including the Hakka population of China and Czech cohorts, have identified PINK1 variants as significant contributors to young-onset Parkinson's disease [4][5]. Multi-ancestry genetic studies demonstrate that while PINK1 variants are distributed globally, their frequencies and specific mutations vary across populations [6]. These variants are of particular translational importance because they define a monogenic subtype of Parkinson's disease with clearer molecular mechanisms than sporadic cases, making them valuable targets for therapeutic development and for understanding fundamental disease pathways [1][6][7].